Cargando…

Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer

BACKGROUND AND OBJECTIVE: To assess the efficacy of a Risk-Adapted Ablative Radiotherapy (RAdAR) approach, after intensive induction chemotherapy, in patients with locally advanced pancreatic cancer (LAPC). MATERIAL AND METHODS: Patients with LAPC who received RAdAR following induction chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Gabriella, Simoni, Nicola, Paiella, Salvatore, Rossi, Roberto, Venezia, Martina, Micera, Renato, Malleo, Giuseppe, Salvia, Roberto, Giuliani, Tommaso, Di Gioia, Anthony, Auriemma, Alessandra, Milella, Michele, Guariglia, Stefania, Cavedon, Carlo, Bassi, Claudio, Mazzarotto, Renzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093383/ https://www.ncbi.nlm.nih.gov/pubmed/33959509 http://dx.doi.org/10.3389/fonc.2021.662205

Ejemplares similares

Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy
por: Rossi, Gabriella, et al.
Publicado: (2022)

Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar
por: Mazzarotto, Renzo, et al.
Publicado: (2020)

A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
por: Paiella, Salvatore, et al.
Publicado: (2021)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

Seasonal variations in pancreatic surgery outcome A retrospective time-trend analysis of 2748 Whipple procedures
por: Marchegiani, Giovanni, et al.
Publicado: (2020)

Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?
por: Simoni, Nicola, et al.
Publicado: (2022)

Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer
por: Simoni, Nicola, et al.
Publicado: (2020)

Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review
por: Paiella, Salvatore, et al.
Publicado: (2016)

Treatment Planning in Intraoperative Radiation Therapy (IORT): Where Should We Go?
por: Cavedon, Carlo, et al.
Publicado: (2022)

Percutaneous ablation of pancreatic cancer
por: D’Onofrio, Mirko, et al.
Publicado: (2016)

Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol
por: Malleo, Giuseppe, et al.
Publicado: (2022)

Selective agenesis of pancreatic isthmus parenchyma with preservation of main pancreatic duct continuity, a very rare entity: Case report
por: Paiella, Salvatore, et al.
Publicado: (2014)

Total pancreatectomy and pancreatic fistula: friend or foe?
por: Salvia, Roberto, et al.
Publicado: (2021)

Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020
por: Marchegiani, Giovanni, et al.
Publicado: (2021)

Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis
por: Casolino, Raffaella, et al.
Publicado: (2021)

Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancer
por: Sandini, Marta, et al.
Publicado: (2023)

Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study
por: Paiella, Salvatore, et al.
Publicado: (2022)

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
por: Casolino, R., et al.
Publicado: (2021)

Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center
por: Paiella, Salvatore, et al.
Publicado: (2017)

A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy
por: Landoni, Luca, et al.
Publicado: (2021)

A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing
por: Paiella, S., et al.
Publicado: (2023)

401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience
por: Esposito, Alessandro, et al.
Publicado: (2022)

A Surface Plasmon Resonance Plastic Optical Fiber Biosensor for the Detection of Pancreatic Amylase in Surgically-Placed Drain Effluent
por: Pasquardini, Laura, et al.
Publicado: (2021)

Evidence of glucose absorption in a neoformed intestine
por: Tuveri, Massimiliano, et al.
Publicado: (2022)

Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
por: Paiella, Salvatore, et al.
Publicado: (2023)

Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis
por: Paiella, Salvatore, et al.
Publicado: (2023)

Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma
por: Trestini, Ilaria, et al.
Publicado: (2021)

A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial
por: Simionato, Francesca, et al.
Publicado: (2020)

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging
por: D’Onofrio, Mirko, et al.
Publicado: (2017)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver
por: Frigerio, Isabella, et al.
Publicado: (2022)

Correlation between ADC Histogram-Derived Metrics and the Time to Metastases in Resectable Pancreatic Adenocarcinoma
por: De Robertis, Riccardo, et al.
Publicado: (2022)

Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients
por: Guariglia, Roberto, et al.
Publicado: (2016)

The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer
por: Perri, Giampaolo, et al.
Publicado: (2020)

Current Definition of and Controversial Issues Regarding Postoperative Pancreatic Fistulas
por: Marchegiani, Giovanni, et al.
Publicado: (2019)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
por: Luchini, Claudio, et al.
Publicado: (2020)

“Pure” hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms
por: Mattiolo, Paola, et al.
Publicado: (2022)

Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience
por: Tuveri, Massimiliano, et al.
Publicado: (2022)

Optical Properties of Tensilely Strained Ge Nanomembranes
por: Paiella, Roberto, et al.
Publicado: (2018)

Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma
por: Malleo, Giuseppe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cnns87ogh7it1l98mcrlakhv3d